KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 113 filers reported holding KRYSTAL BIOTECH INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,704 | +12.9% | 144 | +14.3% | 0.00% | – |
| Q2 2023 | $14,792 | +30.1% | 126 | -11.3% | 0.00% | – |
| Q1 2023 | $11,369 | -17.5% | 142 | -18.4% | 0.00% | – |
| Q4 2022 | $13,784 | +72.3% | 174 | +58.2% | 0.00% | – |
| Q3 2022 | $8,000 | +14.3% | 110 | +7.8% | 0.00% | – |
| Q2 2022 | $7,000 | +16.7% | 102 | +9.7% | 0.00% | – |
| Q1 2022 | $6,000 | -60.0% | 93 | -57.3% | 0.00% | – |
| Q4 2021 | $15,000 | +275.0% | 218 | +311.3% | 0.00% | – |
| Q1 2021 | $4,000 | +100.0% | 53 | +35.9% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 39 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |